Reviews
21 February 2012

Effect of Fructose on Body Weight in Controlled Feeding Trials: A Systematic Review and Meta-analysis

Publication: Annals of Internal Medicine
Volume 156, Number 4

Abstract

Background:

The contribution of fructose consumption in Western diets to overweight and obesity in populations remains uncertain.

Purpose:

To review the effects of fructose on body weight in controlled feeding trials.

Data Sources:

MEDLINE, EMBASE, CINAHL, and the Cochrane Library (through 18 November 2011).

Study Selection:

At least 3 reviewers identified controlled feeding trials lasting 7 or more days that compared the effect on body weight of free fructose and nonfructose carbohydrate in diets providing similar calories (isocaloric trials) or of diets supplemented with free fructose to provide excess energy and usual or control diets (hypercaloric trials). Trials evaluating high-fructose corn syrup (42% to 55% free fructose) were excluded.

Data Extraction:

The reviewers independently reviewed and extracted relevant data; disagreements were reconciled by consensus. The Heyland Methodological Quality Score was used to assess study quality.

Data Synthesis:

Thirty-one isocaloric trials (637 participants) and 10 hypercaloric trials (119 participants) were included; studies tended to be small (<15 participants), short (<12 weeks), and of low quality. Fructose had no overall effect on body weight in isocaloric trials (mean difference, −0.14 kg [95% CI, −0.37 to 0.10 kg] for fructose compared with nonfructose carbohydrate). High doses of fructose in hypercaloric trials (+104 to 250 g/d, +18% to 97% of total daily energy intake) lead to significant increases in weight (mean difference, 0.53 kg [CI, 0.26 to 0.79 kg] with fructose).

Limitations:

Most trials had methodological limitations and were of poor quality. The weight-increasing effect of fructose in hypercaloric trials may have been attributable to excess energy rather than fructose itself.

Conclusion:

Fructose does not seem to cause weight gain when it is substituted for other carbohydrates in diets providing similar calories. Free fructose at high doses that provided excess calories modestly increased body weight, an effect that may be due to the extra calories rather than the fructose.

Primary Funding Source:

Canadian Institutes of Health Research. (ClinicalTrials.gov registration number: NCT01363791)

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
International Diabetes Federation. IDF Diabetes Atlas. 5th ed. Brussels: International Diabetes Federation; 2011. Accessed at www.diabetesatlas.org on 22 December 2011.
2.
Ludwig DSPeterson KEGortmaker SL. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet. 2001;357:505-8. [PMID: 11229668]
3.
Schulze MBManson JELudwig DSColditz GAStampfer MJWillett WCet al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA. 2004;292:927-34. [PMID: 15328324]
4.
Ebbeling CBFeldman HAOsganian SKChomitz VREllenbogen SJLudwig DS. Effects of decreasing sugar-sweetened beverage consumption on body weight in adolescents: a randomized, controlled pilot study. Pediatrics. 2006;117:673-80. [PMID: 16510646]
5.
Higgins HL. The rapidity with which alcohol and some sugars may serve as nutriment. Am J Physiol. 1916;41:258-65.
6.
Johnson RJPerez-Pozo SESautin YYManitius JSanchez-Lozada LGFeig DIet al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev. 2009;30:96-116. [PMID: 19151107]
7.
Elliott SSKeim NLStern JSTeff KHavel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr. 2002;76:911-22. [PMID: 12399260]
8.
Bray GANielsen SJPopkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79:537-43. [PMID: 15051594]
9.
Gross LSLi LFord ESLiu S. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the united states: an ecologic assessment. Am J Clin Nutr. 2004;79:774-9. [PMID: 15113714]
10.
Malik VSSchulze MBHu FB. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr. 2006;84:274-88. [PMID: 16895873]
11.
Malik VSWillett WCHu FB. Sugar-sweetened beverages and BMI in children and adolescents: reanalyses of a meta-analysis. Am J Clin Nutr. 2009;89:438-9. [PMID: 19056589]
12.
Vartanian LRSchwartz MBBrownell KD. Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis. Am J Public Health. 2007;97:667-75. [PMID: 17329656]
13.
Forshee RAAnderson PAStorey ML. Sugar-sweetened beverages and body mass index in children and adolescents: a meta-analysis. Am J Clin Nutr. 2008;87:1662-71. [PMID: 18541554]
14.
Mattes RDShikany JMKaiser KAAllison DB. Nutritively sweetened beverage consumption and body weight: systematic review and meta-analysis of randomized experiments. Obes Rev. 2011;12:346-65. [PMID: 20524996]
15.
Bray GA. Soft drink consumption and obesity: it is all about fructose. Curr Opin Lipidol. 2010;21:51-7. [PMID: 19956074]
16.
Lustig RH. Fructose: metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc. 2010;110:1307-21. [PMID: 20800122]
17.
Tappy LLê KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010;90:23-46. [PMID: 20086073]
18.
Sievenpiper JLde Souza RJKendall CWJenkins DJ. Is fructose a story of mice but not men?. J Am Diet Assoc. 2011;111:219-20. [PMID: 21272692]
19.
Livesey GTaylor R. Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr. 2008;88:1419-37. [PMID: 18996880]
20.
Johnson RKAppel LJBrands MHoward BVLefevre MLustig RHet alAmerican Heart Association Nutrition Committee of the Council on NutritionPhysical Activity, and Metabolism and the Council on Epidemiology and Prevention. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2009;120:1011-20. [PMID: 19704096]
21.
U.S. Department of Health and Human Services; U.S. Department of Agriculture. Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010. Washington, DC: U.S. Government Printing Office; 2010.
22.
Panel on MacronutrientsPanel on the Definition of Dietary FiberSubcommittee on Upper Reference Levels of NutrientsSubcommittee on Interpretation and Uses of Dietary Reference Intakesthe Standing Committee on the Scientific Evaluation of Dietary Reference IntakesFood and Nutrition BoardInstitute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: National Academies Pr; 2002.
23.
Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2011. Accessed at www.cochrane-handbook.org on 22 December 2011.
24.
Moher DCook DJEastwood SOlkin IRennie DStroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354:1896-900. [PMID: 10584742]
25.
Moher DLiberati ATetzlaff JAltman DGPRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-9. [PMID: 19622511]
26.
Heyland DKNovak FDrover JWJain MSu XSuchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001;286:944-53. [PMID: 11509059]
27.
Elbourne DRAltman DGHiggins JPCurtin FWorthington HVVail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol. 2002;31:140-9. [PMID: 11914310]
28.
Furukawa TABarbui CCipriani ABrambilla PWatanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol. 2006;59:7-10. [PMID: 16360555]
29.
Curtin FAltman DGElbourne D. Meta-analysis combining parallel and cross-over clinical trials. I: continuous outcomes. Stat Med. 2002;21:2131-44. [PMID: 12210629]
30.
Pelkonen RAro ANikkilä EA. Metabolic effects of dietary fructose in insulin dependent diabetes of adults. Acta Med Scand Suppl. 1972;542:187-93. [PMID: 4579750]
31.
McAteer EJO'Reilly GHadden DR. The effects of one month high fructose intake on plasma glucose and lipid levels in non-insulin-dependent diabetes. Diabet Med. 1987;4:62-4. [PMID: 2951223]
32.
Osei KFalko JBossetti BMHolland GC. Metabolic effects of fructose as a natural sweetener in the physiologic meals of ambulatory obese patients with type II diabetes. Am J Med. 1987;83:249-55. [PMID: 3618627]
33.
Grigoresco CRizkalla SWHalfon PBornet FFontvieille AMBros Met al. Lack of detectable deleterious effects on metabolic control of daily fructose ingestion for 2 mo in NIDDM patients. Diabetes Care. 1988;11:546-50. [PMID: 3203571]
34.
Thorburn AWCrapo PABeltz WFWallace PWitztum JLHenry RR. Lipid metabolism in non-insulin-dependent diabetes: effects of long-term treatment with fructose-supplemented mixed meals. Am J Clin Nutr. 1989;50:1015-22. [PMID: 2683716]
35.
Anderson JWStory LJZettwoch NCGustafson NJJefferson BS. Metabolic effects of fructose supplementation in diabetic individuals. Diabetes Care. 1989;12:337-44. [PMID: 2721342]
36.
Osei KBossetti B. Dietary fructose as a natural sweetener in poorly controlled type 2 diabetes: a 12-month crossover study of effects on glucose, lipoprotein and apolipoprotein metabolism. Diabet Med. 1989;6:506-11. [PMID: 2527132]
37.
Thorburn AWCrapo PAGriver KWallace PHenry RR. Long-term effects of dietary fructose on carbohydrate metabolism in non-insulin-dependent diabetes mellitus. Metabolism. 1990;39:58-63. [PMID: 2403621]
38.
Blayo AFontveille AMRizkalla SBruzzo FSlama G. Effets metaboliques de la consommation quotidienne pendant un an de saccharose ou de fructose par des diabetiques. Médecine et Nutrition. 1990;26:909-13.
39.
Bantle JPSwanson JEThomas WLaine DC. Metabolic effects of dietary fructose in diabetic subjects. Diabetes Care. 1992;15:1468-76. [PMID: 1468273]
40.
Koivisto VAYki-Järvinen H. Fructose and insulin sensitivity in patients with type 2 diabetes. J Intern Med. 1993;233:145-53. [PMID: 8433075]
41.
Malerbi DAPaiva ESDuarte ALWajchenberg BL. Metabolic effects of dietary sucrose and fructose in type II diabetic subjects. Diabetes Care. 1996;19:1249-56. [PMID: 8908389]
42.
Vaisman NNiv EIzkhakov Y. Catalytic amounts of fructose may improve glucose tolerance in subjects with uncontrolled non-insulin-dependent diabetes. Clin Nutr. 2006;25:617-21. [PMID: 16403592]
43.
Rizkalla SWBaigts FFumeron FRabillon BBayn PKtorza Aet al. Comparative effects of several simple carbohydrates on erythrocyte insulin receptors in obese subjects. Pharmacol Biochem Behav. 1986;25:681-8. [PMID: 3534894]
44.
Swarbrick MMStanhope KLElliott SSGraham JLKrauss RMChristiansen MPet al. Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. Br J Nutr. 2008;100:947-52. [PMID: 18384705]
45.
Stanhope KLSchwarz JMKeim NLGriffen SCBremer AAGraham JLet al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119:1322-34. [PMID: 19381015]
46.
Madero MArriaga JCJalal DRivard CMcFann KPérez-Méndez Oet al. The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: a randomized controlled trial. Metabolism. 2011;60:1551-9. [PMID: 21621801]
47.
Kaufmann Poznanski RBlondheim SHStein Y. Effect of fructose, glucose, sucrose and starch on serum lipids in carbohydrate induced hypertriglyceridemia and in normal subjects. Isr J Med Sci. 1966;2:715-26. [PMID: 5956687]
48.
Förster HHeller G. [Studies on the significance of carbohydrates in a fully synthetic fat-free diet]. Dtsch Med Wochenschr. 1973;98:1156-63. [PMID: 4711888]
49.
Turner JLBierman ELBrunzell JDChait A. Effect of dietary fructose on triglyceride transport and glucoregulatory hormones in hypertriglyceridemic men. Am J Clin Nutr. 1979;32:1043-50. [PMID: 433820]
50.
Beck-Nielsen HPedersen OLindskov HO. Impaired cellular insulin binding and insulin sensitivity induced by high-fructose feeding in normal subjects. Am J Clin Nutr. 1980;33:273-8. [PMID: 6986758]
51.
Swanson JELaine DCThomas WBantle JP. Metabolic effects of dietary fructose in healthy subjects. Am J Clin Nutr. 1992;55:851-6. [PMID: 1550068]
52.
Bantle JPRaatz SKThomas WGeorgopoulos A. Effects of dietary fructose on plasma lipids in healthy subjects. Am J Clin Nutr. 2000;72:1128-34. [PMID: 11063439]
53.
Ngo Sock ETLê KAIth MKreis RBoesch CTappy L. Effects of a short-term overfeeding with fructose or glucose in healthy young males. Br J Nutr. 2010;103:939-43. [PMID: 19930762]
54.
Aeberli IGerber PAHochuli MKohler SHaile SRGouni-Berthold Iet al. ow to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. Am J Clin Nutr. 2011;94:479-85. [PMID: 21677052]
55.
Brymora A, Flisinski M, Johnson RJ, Goszka G, Stefanska A, Manitius J. Low-fructose diet lowers blood pressure and inflammation in patients with chronic kidney disease. Nephrol Dial Transplant. 2011 May 25. [Epub ahead of print]. [ 21613382]
56.
Silbernagel GMachann JUnmuth SSchick FStefan NHäring HUet al. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. Br J Nutr. 2011;106:79-86. [PMID: 21396140]
57.
Stanhope KLGriffen SCBremer AAVink RGSchaefer EJNakajima Ket al. Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions. Am J Clin Nutr. 2011;94:112-9. [PMID: 21613559]
58.
Rizkalla SWBaigts FFumeron FGrigoresco CJean-Joseph-Halfon PApfelbaum Met al. [Influence of fructose on erythrocyte insulin receptors in obese diabetics and non-diabetics]. Journ Annu Diabetol Hotel Dieu. 1986;:207-17. [PMID: 3613367]
59.
Lê KAFaeh DStettler RIth MKreis RVermathen Pet al. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr. 2006;84:1374-9. [PMID: 17158419]
60.
Le KAIth MKreis RFaeh DBortolotti MTran Cet al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr. 2009;89:1760-5. [PMID: 19403641]
61.
Sobrecases HLe KABortolotti MSchneiter PIth MKreis Ret al. Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men. Diabetes Metab. 2010;36:244-6. [PMID: 20483648]
62.
Boutron IMoher DAltman DGSchulz KFRavaud PCONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148:295-309. [PMID: 18283207]
63.
Dekker MJSu QBaker CRutledge ACAdeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab. 2010;299:685-94. [PMID: 20823452]
64.
McDevitt RMPoppitt SDMurgatroyd PRPrentice AM. Macronutrient disposal during controlled overfeeding with glucose, fructose, sucrose, or fat in lean and obese women. Am J Clin Nutr. 2000;72:369-77. [PMID: 10919929]
65.
Malik VSPopkin BMBray GADesprés JPHu FB. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation. 2010;121:1356-64. [PMID: 20308626]
66.
Sievenpiper JLCarleton AJChatha SJiang HYde Souza RJBeyene Jet al. Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans. Diabetes Care. 2009;32:1930-7. [PMID: 19592634]
67.
Mozaffarian DHao TRimm EBWillett WCHu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364:2392-404. [PMID: 21696306]
68.
Lathyris DNTrikalinos TAIoannidis JP. Evidence from crossover trials: empirical evaluation and comparison against parallel arm trials. Int J Epidemiol. 2007;36:422-30. [PMID: 17301102]
69.
Marriott BPCole NLee E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr. 2009;139:1228S-35S. [PMID: 19403716]
70.
Sievenpiper JL, Carleton AJ, Mirrahimi A, Yu ME, de Souza RJ, Beyene J, et al. Fructose has heterogeneous effects on body weight in diabetes: systematic review and meta-analyses of experimental clinical trials. Proceedings of the 28th International Symposium on Diabetes and Nutrition, Oslo, Norway, 1–4 July 2010.
71.
Sievenpiper JL, Yu ME, Carleton AJ, Mirrahimi A, de Souza RJ, Beyene J, et al. Effect of fructose on body weight: a systematic review and meta-analysis of controlled feeding trials. Proceedings of the International Diabetes Federation (IDF), 2011 World Diabetes Congress, Dubai, United Arab Emirates, 4–8 December 2011. Abstract O-0476.

Information & Authors

Information

Published In

cover image Annals of Internal Medicine
Annals of Internal Medicine
Volume 156Number 421 February 2012
Pages: 291 - 304

History

Published online: 21 February 2012
Published in issue: 21 February 2012

Keywords

Authors

Affiliations

John L. Sievenpiper, MD, PhD
From Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Clinical Nutrition and Risk Factor Modification Centre, Division of Endocrinology and Metabolism, and Keenan Research Center of the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Faculty of Medicine and Dalla Lana School of Public Health, University of Toronto, Heart and Stroke Foundation of Ontario, and Research Institute Hospital for Sick Children, Toronto, Ontario, Canada;
Harvard School of Public Health, Boston, Massachusetts; and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Russell J. de Souza, ScD, RD
From Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Clinical Nutrition and Risk Factor Modification Centre, Division of Endocrinology and Metabolism, and Keenan Research Center of the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Faculty of Medicine and Dalla Lana School of Public Health, University of Toronto, Heart and Stroke Foundation of Ontario, and Research Institute Hospital for Sick Children, Toronto, Ontario, Canada;
Harvard School of Public Health, Boston, Massachusetts; and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Arash Mirrahimi, HBSc
From Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Clinical Nutrition and Risk Factor Modification Centre, Division of Endocrinology and Metabolism, and Keenan Research Center of the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Faculty of Medicine and Dalla Lana School of Public Health, University of Toronto, Heart and Stroke Foundation of Ontario, and Research Institute Hospital for Sick Children, Toronto, Ontario, Canada;
Harvard School of Public Health, Boston, Massachusetts; and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Matthew E. Yu, HBSc
From Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Clinical Nutrition and Risk Factor Modification Centre, Division of Endocrinology and Metabolism, and Keenan Research Center of the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Faculty of Medicine and Dalla Lana School of Public Health, University of Toronto, Heart and Stroke Foundation of Ontario, and Research Institute Hospital for Sick Children, Toronto, Ontario, Canada;
Harvard School of Public Health, Boston, Massachusetts; and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Amanda J. Carleton, MSc
From Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Clinical Nutrition and Risk Factor Modification Centre, Division of Endocrinology and Metabolism, and Keenan Research Center of the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Faculty of Medicine and Dalla Lana School of Public Health, University of Toronto, Heart and Stroke Foundation of Ontario, and Research Institute Hospital for Sick Children, Toronto, Ontario, Canada;
Harvard School of Public Health, Boston, Massachusetts; and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Joseph Beyene, PhD
From Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Clinical Nutrition and Risk Factor Modification Centre, Division of Endocrinology and Metabolism, and Keenan Research Center of the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Faculty of Medicine and Dalla Lana School of Public Health, University of Toronto, Heart and Stroke Foundation of Ontario, and Research Institute Hospital for Sick Children, Toronto, Ontario, Canada;
Harvard School of Public Health, Boston, Massachusetts; and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Laura Chiavaroli, MSc
From Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Clinical Nutrition and Risk Factor Modification Centre, Division of Endocrinology and Metabolism, and Keenan Research Center of the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Faculty of Medicine and Dalla Lana School of Public Health, University of Toronto, Heart and Stroke Foundation of Ontario, and Research Institute Hospital for Sick Children, Toronto, Ontario, Canada;
Harvard School of Public Health, Boston, Massachusetts; and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Marco Di Buono, PhD
From Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Clinical Nutrition and Risk Factor Modification Centre, Division of Endocrinology and Metabolism, and Keenan Research Center of the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Faculty of Medicine and Dalla Lana School of Public Health, University of Toronto, Heart and Stroke Foundation of Ontario, and Research Institute Hospital for Sick Children, Toronto, Ontario, Canada;
Harvard School of Public Health, Boston, Massachusetts; and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Alexandra L. Jenkins, PhD, RD
From Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Clinical Nutrition and Risk Factor Modification Centre, Division of Endocrinology and Metabolism, and Keenan Research Center of the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Faculty of Medicine and Dalla Lana School of Public Health, University of Toronto, Heart and Stroke Foundation of Ontario, and Research Institute Hospital for Sick Children, Toronto, Ontario, Canada;
Harvard School of Public Health, Boston, Massachusetts; and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Lawrence A. Leiter, MD
From Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Clinical Nutrition and Risk Factor Modification Centre, Division of Endocrinology and Metabolism, and Keenan Research Center of the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Faculty of Medicine and Dalla Lana School of Public Health, University of Toronto, Heart and Stroke Foundation of Ontario, and Research Institute Hospital for Sick Children, Toronto, Ontario, Canada;
Harvard School of Public Health, Boston, Massachusetts; and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Thomas M.S. Wolever, MD, PhD
From Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Clinical Nutrition and Risk Factor Modification Centre, Division of Endocrinology and Metabolism, and Keenan Research Center of the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Faculty of Medicine and Dalla Lana School of Public Health, University of Toronto, Heart and Stroke Foundation of Ontario, and Research Institute Hospital for Sick Children, Toronto, Ontario, Canada;
Harvard School of Public Health, Boston, Massachusetts; and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Cyril W.C. Kendall, PhD
From Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Clinical Nutrition and Risk Factor Modification Centre, Division of Endocrinology and Metabolism, and Keenan Research Center of the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Faculty of Medicine and Dalla Lana School of Public Health, University of Toronto, Heart and Stroke Foundation of Ontario, and Research Institute Hospital for Sick Children, Toronto, Ontario, Canada;
Harvard School of Public Health, Boston, Massachusetts; and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
David J.A. Jenkins, MD, PhD, DSc
From Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Clinical Nutrition and Risk Factor Modification Centre, Division of Endocrinology and Metabolism, and Keenan Research Center of the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Faculty of Medicine and Dalla Lana School of Public Health, University of Toronto, Heart and Stroke Foundation of Ontario, and Research Institute Hospital for Sick Children, Toronto, Ontario, Canada;
Harvard School of Public Health, Boston, Massachusetts; and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Note: Aspects of this work were presented in abstract form at the 28th Internal Symposium on Diabetes and Nutrition Oslo, Norway, 1–4 July 2010 (70), and the International Diabetes Federation, World Diabetes Congress 2011, Dubai, United Arab Emirates, 4–8 December 2011 (71).
Disclosures: Dr. Sievenpiper: Grant (money to institution): Canadian Institutes of Health Research, Calorie Control Council; Support for travel to meetings for the study or other purposes: The Coca-Cola Company; Consultancy: Abbott Laboratories, International Life Sciences Institute (ILSI) North America, Archer Daniels Midland; Grants/grants pending (money to institution): The Coca-Cola Company; Travel/accommodations/meeting expenses unrelated to activities listed (money to institution): The Coca-Cola Company, Pulse Canada, Canadian Diabetes Association; Other: Director of BDSK Consulting. Dr. de Souza: Grant: Canadian Institutes of Health Research; Grant (money to institution): Calorie Control Council, Canadian Institutes of Health Research Grants/grants pending (money to institution): The Coca-Cola Company. Dr. Beyene: Grant (money to institution): Canadian Institutes of Health Research, Calorie Control Council; Grants/grants pending (money to institution): The Coca-Cola Company. Ms. Chiavaroli: Other: casual position as a clinical research coordinator at Glycemic Index Laboratories. Dr. A. Jenkins: Grant (money to institution): Canadian Institutes of Health Research; Employment: Part owner and Director of Research at Glycemic Index Laboratories; Grants/grants pending (money to institution): Canadian Diabetes Association; Travel/accommodations/meeting expenses unrelated to activities listed: Canadian Diabetes Association. Dr. Wolever: Grant (money to institution): Canadian Institutes of Health Research. Board membership: Glycemic Index Laboratories; Consultancy: McCain Foods, Temasek Polytechnic; Employment: Glycemic Index Laboratories, Glycaemic Index Testing; Grants/grants pending (money to institution): Canadian Institutes of Health Research, Dairy Farmers of Canada, Canadian Diabetes Association; Payment for lectures including service on speakers bureaus: Northwestern University; Royalties: Phillipa Sandall Publishing Services, CABI Publishers; Travel/accommodations/meetings expenses unrelated to activities listed: Royal Society of London, Glycemic Index Symbol program, CreaNutrition AG, McMaster University, Canadian Society for Nutritional Sciences, National Sports and Conditioning Association, Faculty of Public Health and Nutrition—Autonomous University of Nuevo Leon, Diabetes and Nutrition Study Group of the EASD. Dr. Kendall: Grant (money to institution): Canadian Institutes of Health Research, Calorie Control Council; Grants/grants pending (money to institution): The Coca-Cola Company, Almond Board of California, International Tree Nut Council, Barilla, Solae, Unilever, Saskatchewan Pulse Growers, Pulse Canada; Payment for lectures including service on speakers bureaus: Danone, Almond Board of California, Kellogg, Solae; Travel/accommodations/meeting expenses unrelated to activities listed: International Tree Nut Council, Saskatchewan Pulse Growers, Pulse Canada. Dr. D. Jenkins: Grant (money to institution): Barilla, Solae, Unilever, Haine Celestial, Loblaws Supermarkets, Sanitarium Company, Almond Board of California, Orafti, Canadian Institutes of Health Research, Canadian Foundation for Innovation, Ontario Research Fund, Advanced Foods and Material Network, The International Tree Nut Council Nutrition Research & Education, The Peanut Institute; Consulting fee or honorarium: Solae, Oldways Preservation Trust, Almond Board of California, Kellogg's, Quaker Oats, Procter and Gamble Technical Centre Limited, The Coca-Cola Sugar Advisory Board, Griffin Hospital for the development of the NuVal System, Abbott Laboratories, The Canola and Flax Councils of Canada, Soy Advisory Board of Dean Foods, The California Strawberry Commission, The International Tree Nut Council Nutrition Research & Education, The Peanut Institute, Barilla, Unilever, Haine Celestial, Loblaws Supermarkets; Support for travel to meetings for the study or other purposes: Almond Board of California, The International Tree Nut Council Nutrition Research & Education, The Peanut Institute, Alpro Soy Foundation, Soy Advisory Board of Dean Foods; Board membership: Loblaws Supermarkets, Sanitarium Company, Herbalife International, Nutritional Fundamentals for Health, Pacific Health Laboratories, Metagenics/MetaProteomics, Bayer Consumer Care, The California Strawberry Commission, Orafti, Science Advisory Council Agrifoods and Agriculture, Canadian Agriculture Policy Institute, Soy Advisory Board of Dean Foods, Kellogg's, Quaker Oats, Procter and Gamble Technical Centre Limited, The Coca-Cola Sugar Advisory Board, Griffin Hospital for the development of the NuVal System, Abbott Laboratories, The Canola and Flax Councils of Canada, Pulse Canada, Saskatchewan Pulse Growers; Consultancy: Solae, Oldways Preservation Trust, Almond Board of California, Kellogg's, Quaker Oats, Procter and Gamble Technical Centre Limited, The Coca-Cola Sugar Advisory Board, Griffin Hospital for the development of the NuVal System, Abbott Laboratories, The Canola and Flax Councils of Canada, Soy Advisory Board of Dean Foods, The California Strawberry Commission, The International Tree Nut Council Nutrition Research & Education, The Peanut Institute, Barilla, Unilever, Haine Celestial, Loblaws Supermarkets; Stock/stock options: Pacific Health Laboratories; Other: Spouse (Dr. Alexandra L. Jenkins) is a Director and Partner with Glycemic Index Laboratories, which tests foods for glycemic index used in his studies. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M11-1669.
Corresponding Author: David J.A. Jenkins, MD, PhD, DSc, Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, The FitzGerald Building, Room 340, 150 College Street, Toronto, Ontario M5S 3E2, Canada; e-mail, [email protected].
Current Author Addresses: Dr. Sievenpiper: Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University, HSC-2N22B, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada.
Drs. de Souza and Beyene: Department of Clinical Epidemiology & Biostatistics, Faculty of Health Sciences, McMaster University, 1200 Main Street West, MDCL 3208, Hamilton, Ontario L8N 3Z5, Canada.
Mr. Mirrahimi, Mr. Yu, Ms. Chiavaroli, and Dr. A.L. Jenkins: Risk Factor Modification Centre, St. Michael's Hospital, 61 Queen Street East, #6130, Toronto, Ontario M5C 2T2, Canada.
Ms. Carleton: Undergraduate Medical Education, Faculty of Medicine, University of Toronto Medical Sciences Building, 1 King's College Circle, Room 2111, Toronto, Ontario M5S 1A8, Canada.
Dr. Di Buono: Heart and Stroke Foundation, 2300 Yonge Street, Suite 1300, PO Box 2414, Toronto, Ontario M4P 1E4, Canada.
Dr. Leiter: Division of Endocrinology and Metabolism, St. Michael's Hospital, 61 Queen Street East, #6121, Toronto, Ontario M5C 2T2, Canada.
Drs. Wolever: Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, The FitzGerald Building, Room 434, 150 College Street, Toronto, Ontario M5S 3E2, Canada.
Drs. Kendall and D.J.A. Jenkins: Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, The FitzGerald Building, Room 340, 150 College Street, Toronto, Ontario M5S 3E2, Canada.
Author Contributions: Conception and design: J.L. Sievenpiper, J. Beyene, L.A. Leiter, D.J.A. Jenkins.
Analysis and interpretation of the data: J.L. Sievenpiper, R.J. de Souza, M.E. Yu, J. Beyene, L.A. Leiter, D.J.A. Jenkins.
Drafting of the article: J.L. Sievenpiper.
Critical revision of the article for important intellectual content: J.L. Sievenpiper, R.J. de Souza, A. Mirrahimi, M.E. Yu, A.J. Carleton, J. Beyene, L. Chiavaroli, M. Di Buono, A.L. Jenkins, L.A. Leiter, T.M.S. Wolever, C.W.C. Kendall, D.J.A. Jenkins.
Final approval of the article: J.L. Sievenpiper, R.J. de Souza, A. Mirrahimi, M.E. Yu, A.J. Carleton, J. Beyene, L. Chiavaroli, M. Di Buono, A.L. Jenkins, L.A. Leiter, T.M.S. Wolever, C.W.C. Kendall, D.J.A. Jenkins.
Statistical expertise: R.J. de Souza, J. Beyene.
Obtaining of funding: J.L. Sievenpiper, R.J. de Souza, A. Mirrahimi, A.J. Carleton, J. Beyene, M.D. Di Buono, A.L. Jenkins, L.A. Leiter, T.M.S. Wolever, D.J.A. Jenkins.
Administrative, technical, or logistic support: A. Mirrahimi, L. Chiavaroli, C.W.C. Kendall.
Collection and assembly of data: J.L. Sievenpiper, R.J. de Souza, A. Mirrahimi, M.E. Yu, A.J. Carleton, L. Chiavaroli.

Metrics & Citations

Metrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
John L. Sievenpiper, Russell J. de Souza, Arash Mirrahimi, et al. Effect of Fructose on Body Weight in Controlled Feeding Trials: A Systematic Review and Meta-analysis. Ann Intern Med.2012;156:291-304. [Epub 21 February 2012]. doi:10.7326/0003-4819-156-4-201202210-00007

View More

Get Access

Login Options:
Purchase

You will be redirected to acponline.org to sign-in to Annals to complete your purchase.

Create your Free Account

You will be redirected to acponline.org to create an account that will provide access to Annals.

View options

PDF/ePub

View PDF/ePub

Related in ACP Journals

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media